Supportive treatment of liver disease
US7977326B2 · kind B2 · utility
0Cited by
2References
4Claims
0Family size
Inventor
Key dates
| Filing date | Apr 21, 2005 |
| Grant date | Jul 12, 2011 |
| Priority date | — |
| Expiry date | Jul 23, 2026 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P1/16
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides a composition and method for treatment of a subject suffering from liver disease comprising the oral administration of a slow release formulation of calcium channel blocker such as diltiazem and thiamine which is also an antioxidant which is relatively hydrophilic when compared with the calcium channel blocker.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.